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The early experience at the University ofMichigan 
with the Rashkind ASD occluder in three children 
with a secundum atrial septal defect (ASD) is re- 
ported. Successfl transcatheter ASD closure was 
accomplished in one child. The procedure was not 
successjul in the other two. In one, the ASD oc- 
cluder was inadvertently implanted in the right 
atrium. The ASD was successfully closed in the 
Introduction 
During the past several years therapeutic cathe- 
terization techniques have been developed to pro- 
vide nonsurgical treatment for children with con- 
genital aortic valve stenosis,',2 subvalvar aortic ste- 
n o ~ i s , ~  mitral s ten~s is ,~ ,~  and coarctation of the 
a ~ r t a . ~ , ~  Transcatheter therapy is now generally re- 
garded as the treatment of choice for children with 
valvar pulmonic stenosis, pulmonary artery steno- 
sis, or postoperative recoarctation of the aorta8 
Transcatheter methods for closing shunt lesions 
have also been developed. Patent ductus arteriosus 
can be closed in the cardiac catheterization labora- 
tory using a double-umbrella occluding d e ~ i c e . ~  
Similarly, transcatheter closure of a secundum 
atrial septal defect (ASD) appears to be feasi- 
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other child, but the occluder device partially de- 
tached from the atrial septum 4 days later and 
required emergency surgical retrieval from the It$ 
atrium. Based on this early experience, revisions 
in the occluder device and the technique of its de- 
livery are suggested that should improve the safi;y 
and eficacy of transcatheter ASD occlusion in the 
jkture. (J Interven Cardiol 1989:21) 
ble.'o,ll. Since ASD accounts for approximately 8% 
of all congenital heart disease, the development of 
an effective nonsurgical technique for ASD closure 
would have an important impact on the treatment 
of children with heart disease. 
In 1976, Mills and King reported the first trans- 
catheter closure of a secundum atrial septal defect 
in humans using a double-umbrella device." Dur- 
ing the 1970s, Rashkind also developed a trans- 
catheter closure device for use in patients with a 
secundum ASD." Based on Rashkind's work in 
animals and humans, his occluder device has un- 
dergone multiple revisions. It currently consists of 
a single polyurethane foam disc supported by six 
stainless steel arms three of which support hooks 
designed to anchor the device to the atrial septum. 
The device is appropriate for closure of a small to 
moderate ASD measuring <20 mm in its widest 
diameter, and has been approved recently by the 
FDA for clinical trials. The purpose of the present 
report is to describe our early experience with the 
Rashkind ASD occluder, and to recommend 
changes that may improve the safety and efficacy 
of transcatheter ASD occlusion in the future. 
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Technique 
Transcatheter ASD closure is presently an in- 
vestigational procedure and has been approved by 
the institutional review board at our hospital. Ap- 
propriate informed consent is obtained, and surgi- 
cal backup is available for all patients. The Rash- 
kind ASD occluder (Fig. 1; USCI, Tewksbury, 
MA) is available in three sizes: 25 mm, 30 mm, 
and 35 mm in diameter, We prefer to utilize an 
occluder whose diameter is approximately twice 
the largest diameter of the ASD. After the femoral 
vein is dilated serially with a 10, 12, and 14 Fr 
dilator, a long 16 Fr sheath is introduced percuta- 
neously and advanced to the left atrium." With 
careful technique, we feel that the 16 Fr venous 
sheath can be safely used in children as small as 10 
kilograms. The delivery system, with a collapsed 
occluder within its pod, is advanced through the 
sheath, across the ASD to the left atrium. Biplane 
fluoroscopy, and more recently two-dimensional 
echocardiography as well, is utilized to assure that 
the tip of the delivery system is located in the mid- 
portion of the left atrium. The venous sheath and 
pod are then retracted and the occluder is ad- 
vanced slightly until it exits the delivery pod and 
opens within the left atrium. As the delivery cath- 
eter is then withdrawn, its centering arms guide the 
occluder device to the ASD. Firm traction is ex- 
erted on the catheter to embed the anchoring 
hooks firmly into the atrial septum. When all three 
hooks are seated, the occluder device is released 
from the catheter and the delivery system is re- 
moved from the femoral vein. A repeat right heart 
Figure 1. A 25-mm Rashkind ASD occluder device. The prosthesis is constructed of a hexagon of polyurethane foam material supported by 
six stainless steel arms. The arms are hinged centrally (not shown) to enable the device to fold into the delivery pod. Three of the a r m s  are 
hooked to anchor the device to the atrial septum. In the center of the prosthesis is a beaded pin used to fasten the occluder to the delivery 
catheter. 
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catheterization is performed to quantitate any re- 
sidual shunt that may be present. A pulmonary 
arteriogram is filmed to visualize the presence or 
absence of an atrial shunt on the levophase. 
Animal Experiments 
Prior to performing transcatheter ASD occlu- 
sion in humans, we utilized the technique to close 
an experimental ASD in four adult mongrel dogs. 
Each dog was anesthetized with intravenous suri- 
tol. The right femoral vein was entered percutane- 
ously, and the left atrium catheterized transsep- 
tally using a Brockenbrough needle and a 7 Fr 
Mullins sheath. The atrial septal puncture was di- 
lated with a 10-mm balloon angioplasty catheter 
(Mansfield Scientific, Mansfield, MA, USA) to 
create a small ASD. Transcatheter ASD occlusion 
was then performed as described above, utilizing a 
25-mm Rashkind occluder device. Each animal 
was sacrificed immediately and the heart exam- 
ined. 
In three animals the ASD occluder was properly 
seated on the left atrial septal surface, resulting in 
complete closure of the ASD. In a fourth animal, 
one of the anchoring hooks had caught within the 
left atrial appendage and caused the occluder to be 
malaligned as it was delivered to the atrial septum. 
Upon gross inspection, the prosthesis was only 
partially attached to the septum and did not oc- 
clude the ASD. No gross injury to the mitral valve 
was apparent. 
Case Reports 
Patient 1 was a 3-year-old, 11.1 kg, girl with a 
moderate secundum ASD. At cardiac catheteriza- 
tion the Qp/Qs ratio was 1.8, and the ASD diame- 
ter measured 13 mm by angiography. Transcath- 
eter ASD closure was attempted using a 25-mm 
Rashkind occluder device. Under biplane fluoro- 
scopic guidance the delivery pod was positioned in 
the left atrium, close to the atrial septum in an 
attempt to decrease the chance that an occluder 
hook might engage the atrial appendage or a pul- 
monary vein orifice. However, when the occluder 
was advanced from the delivery pod, it opened 
within the ASD and pulled itself through to the 
right atrium. The anchoring hooks attached to the 
lateral right atrial wall, and the device could not be 
retrieved transvenously. The inadvertent right 
atrial position of the occluder was confirmed by 
echocardiography. Later that evening the patient 
was taken to the operating room, where the oc- 
cluder device was removed and the ASD repaired 
without complication. There was no apparent in- 
jury to the right atrial wall, eustachian valve or the 
tricuspid valve. 
Patient 2 was an 8-year-old, 22 kg, boy also with 
a moderate secundum ASD. The diagnosis was 
confirmed at cardiac catheterization where the 
Qp/Qs ratio was 1.8, and the defect measured 13 
mm in diameter by angiography. Because of the 
difficulty we encountered properly positioning the 
device in Patient I, both biplane fluoroscopy and 
two-dimensional echocardiography were utilized 
to assure that the delivery pod and the occluder 
were located in the midportion of the left atrium 
prior to seating the device on the atrial septum. 
Successful transcatheter ASD closure was accom- 
plished using a 25-mm Rashkind occluder, and the 
entire procedure 1 ook approximately 30 minutes 
(Fig. 2). The Qp/Qs ratio decreased from 1.8 to 
1.1. A small residual left-to-right shunt was evi- 
dent at the superior margin of the occluder by an- 
giography and by Doppler echocardiography. 
Prior to discharge home the following day the 
child’s physical exam had nearly normalized, al- 
though the second heart sound remained widely 
split. Mild cardiomegaly noted on chest X ray 
prior to ASD occlusion, had resolved. 
A follow-up evaluation 6 months after the pro- 
cedure indicated that the residual small left-to- 
right shunt was no longer present. The physical 
exam, including the second heart sound, was com- 
pletely normal. A two-dimensional echocardio- 
gram documented a normal right ventricular di- 
mension, normal septal motion, and there was no 
evidence of an atrial shunt by Doppler echocar- 
diography. A radionuclide shunt study revealed no 
evidence of a residual shunt. 
Patient 3 was a 6-year-old, 20 kg, boy with a 
small secundum ASD. Cardiac catheterization 
documented a Qp/Qs ratio of 1.6, and the defect 
measured 7 mm in diameter by angiography. The 
defect was occluded with a 25-mm Rashkind oc- 
cluder, again utilizing biplane fluoroscopy and 
echocardiography to position the device properly 
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Figure 2. Two-dimensional echocardiogram, 4-chamber view, of Patient 2 before (upper panel) 
and after (lower panel) successful transcatheter ASD occlusion. In the upper panel, a 13-mm 
secundum ASD is evident (arrow). In the lower panel a 25-mm Rashkind occluder device 
(arrow) has successfully occluded the defect. A small residual shunt at the margin of the device 
resolved 6 months after the procedure. 
in the left atrium prior to occlusion. Immediately 
after ASD occlusion, one of the three hooked arms 
was noted to be bent slightly and did not appear to 
be attached firmly to the septum. Nevertheless, the 
ASD was nearly occluded completely as only a 
very small residual shunt was detected angiograph- 
id ly .  The patient was observed in a moderate care 
setting for two days. The physical exam normal- 
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ized, and a repeat chest X ray and two-dimen- 
sional echocardiogram documented that the de- 
vice remained positioned properly on the atrial 
septum. A radionuclide shunt scan was normal, 
measuring a Qp/Qs ratio of 1.03. 
Four days following transcatheter ASD occlu- 
sion the child complained of palpitations. He was 
readmitted to the hospital where he was found to 
have sinus tachycardia, a widely split second 
sound, and murmurs of mitral stenosis and regur- 
gitation. A two-dimensional echocardiogram re- 
vealed that the occluder device had detached par- 
tially from the atrial septum, and had rotated away 
from the septum to lie just above the mitral valve 
(Fig. 3). The patient was taken emergently to sur- 
gery where the occluder was removed and the ASD 
repaired. A tiny puncture in the posterior leaflet of 
the mitral valve was sutured. Postoperatively the 
child has done well, With only trivial mitral regur- 
gitation evident 1 year following surgical repair. 
Discussion 
Clinical experience using the Rashkind ASD oc- 
cluder has been extremely limited. Rashkind has 
reported his early experience using the single-disc 
occluder to close a small to moderate sized secun- 
dum ASD in 23 children and adults.”-” Satisfac- 
tory closure was achieved in 14 patients (61%). 
However, in nine the closure was considered un- 
satisfactory because of improper implantation or 
the persistence of a significant left-to-right shunt. 
Six of these nine children subsequently underwent 
surgical ASD repair. Retrieval of the occluder de- 
vice and surgical ASD closure were reportedly un- 
complicated. 
Our preliminary experience with the Rashkind 
ASD occluder device in three children with a se- 
cundum ASD has also been mixed. Although suc- 
cessful ASD closure was accomplished in one 
child, in two others transcatheter closure was not 
successful and surgical ASD repair was required. 
On the basis of our initial experience a number of 
observations can be made. First, transcatheter 
ASD occlusion is clearly feasible. This is indicated 
both by the successful closure of a moderate se- 
cundum ASD in one child in our series, and by 
Rashkind’s early experience with the prototype 
single-disc ASD occluder. Second, our experience 
indicates that a small residual shunt present at the 
margin of the occluder immediately after trans- 
catheter closure may resolve with time. In patient 
2, a small left-to-right shunt persisted at the upper 
margin of the occluder device after transcatheter 
ASD occlusion. Follow-up physical examinations, 
echocardiograms, and a nuclear shunt scan docu- 
mented that this residual shunt had resolved com- 
pletely by the sixth month after transcatheter clo- 
sure. The process by which this may have occurred 
is unclear, but most likely involves endothelial in- 
growth along the margin of the occluder device. 
Although the series is small, our unsuccessful 
attempts at transcatheter ASD closure in two chil- 
dren highlight several deficiencies in the present 
occluder device and delivery system. First, because 
of its anchoring hooks the current device cannot 
be withdrawn into the delivery system or its posi- 
tion adjusted significantly once it is advanced out 
of the delivery pod. Thus, unlike the double-um- 
brella PDA occluder, the single-disc ASD occluder 
is an “all or none” device whose implantation is 
committed once it is opened within the left (or 
right) atrium. Second, the current ASD occluder 
device may become dislodged from the septum if 
all three hooks are not attached perfectly to the 
atrial septal surface. If only one hook is poorly 
anchored, then 240” of the device remains essen- 
tially unsupported and vulnerable to dislodgement 
as experienced by patient 3 in our series. Third, the 
current delivery system may not deliver the oc- 
cluding device parallel to the atrial septum. As the 
device is pulled toward the left septal surface, the 
delivery catheter is withdrawn inferiorly into the 
inferior vena cava and appears to tilt the occluding 
device so that it is no longer parallel to the atrial 
septum. This may result in malalignment of the 
device on the septum, and incomplete closure of 
the septal defect.13 
These observahons suggest a number of poten- 
tial revisions that may improve the efficacy and 
safety of transcatheter ASD occlusion in the fu- 
ture. Alterations in the ASD occluder device itself 
will be necessary. An occluder device that does not 
attach by hooks to the atrial septum would allow 
the potential benefit of withdrawal back into the 
delivery system if its initial position were deemed 
unsatisfactory. In 1983 Rashkind, recognizing 
similar drawbacks of the single-disc device, pro- 
posed that a double-disc occluding system may be 
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Figure 3. Two-dimensional echocardiogram of Patient 3, obtained 4 days after 
transcatheter ASD occlusion, show that the occluder has partially dislodged from the 
septum. A parasternal long-axis view (upper panel) and apical 4chamber view (lower 
panel) demonstrate that the prosthesis has rotated off of the atrial septum into the left 
atrium. It lies just above the mitral valve, and is drawn into the mitral valve funnel 
during diastole (arrowheads). 
preferable. It is not clear from the description 
whether his double-disc system was dependent 
upon anchoring hooks for attachment to the sep- 
turn. Recently, however, Sideris14 and Rome15 
have demonstrated that a hookless double-disc de- 
vice can be utilized to successfully occlude experi- 
mental atrial septal defects. 
We also recommend that two-dimensional 
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echocardiography be utilized, together with bi- 
plane fluoroscopy, to assist in properly locating 
and positioning the device within the left atrium 
before it is seated on the atrial septum. Echocar- 
diography can accurately determine the location 
of the delivery pod in the midleft atrium before the 
occluder device is opened. We feel that the use of 
echocardiography in Patient 1 may have prevented 
the inadvertent opening of the occluder in the 
proximal left atrium that resulted in its implanta- 
tion along the right atrial wall. Finally, revisions in 
the delivery system must also be considered. For 
example, the use of a curved delivery sheath may 
improve the technique by delivering the occluder 
in a more parallel fashion to the atrial septum. 
Transcatheter occlusion of a secundum ASD is a 
promising, nonsurgical approach to the treatment 
of this common congenital heart defect. The cur- 
rent technique has a number of drawbacks that 
appear to have limited its successful application. 
As highlighted by our experience, these relate both 
to the occluder device itself and to the method of 
its delivery. We are certain, however, that with 
continued experience and appropriate revisions in 
the technique, transcatheter ASD occlusion will 
become a safe and effective treatment for children 
with a secundum ASD in the future. 
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